Budapest, Hungary February 2010 – Ceva Phylaxia, the home of a stream of world famous scientists from Aujeszky to Marek, revealed the latest in a long series of recent investments with the opening of a new bacterial vaccine plant, the latter investment being supported by the Hungarian State. Over 600 invited guests including Mr. René Roudaut (French Ambassador), Mr. László Varjú (State Secretary responsible for development issues - Ministry of National Development and Economy), Dr. Bognár Lajos (Deputy CEO - Central Agriculture Office), Mr. Lajos Verbai (Major of the 10th district), Mr. Csaba Kilián (CEO – ITD Hungary Zrt.) were present at the ceremony.
The new facility will produce innovative aerobic and anaerobic new bacterial vaccines for Ceva’s growing global demand. The E 8.5 m. plant takes combined investment in the Budapest campus to over E 28m. since the programme began in 2002.
Dr. Arnaud Bourgeois, Ceva’s Global Head of Biology, opening the plant said “The Phylaxia company was founded in 1912 – almost 100 years ago, making it one of the oldest vaccines company in the world. At Ceva, we are proud to have inherited this scientific tradition, which since the outset has been based on the simple premise of closely associating high quality science, through production to the needs of our customers, veterinarians and livestock owners. Today, any company to remain competitive needs constant investment and our programme of continual improvement in both the physical plant and human resources will ensure that the Phylaxia campus remains at the centre of our global biologicals network.”
Plus d'information sur le site suivant:
http://www.ceva-us.com/biomune/News/Ceva-celebrates-its-10th-Anniversary-with-the-opening-of-a-new-bacterial-vaccine-facility-at-its-European-biological-centre-of-expertise
